DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Pressemitteilung der Firma Lilly.
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial.
https://investor.lilly.com/node/43706/pdf (14.09.2020)
We do not assume any responsibility for the contents of the web pages of other providers.